662

+1.39%↑

ALV

261.5

+0.93%↑

SAF

202.5

+1.25%↑

BBVA

10.03

+0.05%↑

58.98

+1.17%↑

662

+1.39%↑

ALV

261.5

+0.93%↑

SAF

202.5

+1.25%↑

BBVA

10.03

+0.05%↑

58.98

+1.17%↑

662

+1.39%↑

ALV

261.5

+0.93%↑

SAF

202.5

+1.25%↑

BBVA

10.03

+0.05%↑

58.98

+1.17%↑

662

+1.39%↑

ALV

261.5

+0.93%↑

SAF

202.5

+1.25%↑

BBVA

10.03

+0.05%↑

58.98

+1.17%↑

662

+1.39%↑

ALV

261.5

+0.93%↑

SAF

202.5

+1.25%↑

BBVA

10.03

+0.05%↑

58.98

+1.17%↑

Home・Aktien・Bayer AG

Bayer AG

Open

Branche Finanzen

27.26 2.27

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

26.63

Max

27.275

Schlüsselkennzahlen
By Trading Economics
Einkommen	663M 2B
Verkäufe	1.9B 14B
KGV Branchendurchschnitt	30.9 20.407
EPS	2.82
Gewinnspanne	14.524
EBITDA	1.3B 4.4B

Empfehlungen
By TipRanks
Empfehlungen	Neutral
12-Monats-Prognose	+12.72 upside

Dividenden
By Dow Jones
Nächstes Ergebnis	6. Aug. 2024

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	192M 26B
Vorheriger Eröffnungskurs	24.99
Vorheriger Schlusskurs	27.26

Nachrichtenstimmung

By Acuity

37%

63%

85 / 459 Ranking in Finance

Technischer Score

By Trading Central

Vertrauen

Bullish Evidence

26.36 / 27.295 Unterstützung & Widerstand

Bayer AG Chart

Peer-Vergleich

Kursveränderung

Bayer AG Prognose

Kursziel

By TipRanks

12.72% Vorteil

12-Monats-Prognose

Durchschnitt 30.4 EUR 12.72%

Hoch 34 EUR

Tief 28 EUR

Basierend auf 11 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Bayer AG – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

11 ratings

Buy

Halten

Sell

Basierend auf 11 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Bayer AG – Dist abgegeben haben.

Technischer Score

By Trading Central

26.36 / 27.295Unterstützung & Widerstand

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

All events are bearish.

Stimmung

By Acuity

85 / 459 Ranking in Finanzen

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

EBITDA

Betriebsergebnis

Über Bayer AG

Bayer AG is a German-based life science company. The Company's segments are Pharmaceuticals, Consumer Health, Crop Science and Animal Health. The Pharmaceuticals segment focuses on researching, developing and marketing prescription products and specialty therapeutics especially in the areas of cardiology, oncology, gynecology, hematology and ophthalmology, as well as radiopharmacology and others. The company is focusing on their oncology platform o Targeted Alpha Therapies for treating prostate cancer. Th Consumer Health segment develops, produces and markets nonprescription over-the-counter products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories, among others. The Crop Science segment researches, develops and markets crop protection solutions and seeds, and includes the subsidiary Monsanto. The Animal Health segment is engaged in the development, production and marketing of prescription and non